These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28146005)

  • 1. Elevated C-Reactive Protein in Asymptomatic Crohn's Disease Patients: Listen to the Sound of Silence.
    Pagnini C; Mariani MB; Corleto VD; Delle Fave G
    Inflamm Bowel Dis; 2017 Mar; 23(3):E13. PubMed ID: 28146005
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation between levels of C-reactive protein and clinical activity in Crohn's disease.
    Karoui S; Ouerdiane S; Serghini M; Jomni T; Kallel L; Fekih M; Boubaker J; Filali A
    Dig Liver Dis; 2007 Nov; 39(11):1006-10. PubMed ID: 17889628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein as a predictor of relapse in asymptomatic patients with Crohn's disease.
    André C; Descos L; Vignal J; Gillon J
    Scott Med J; 1983 Jan; 28(1):26-9. PubMed ID: 6403982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Millán-Lorenzo M; Guerrero-Jiménez P; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Jan; 31(1):112-8. PubMed ID: 26173493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A family study of asymptomatic small bowel Crohn's disease.
    Biancone L; Calabrese E; Petruzziello C; Capanna A; Zorzi F; Onali S; Condino G; Lolli E; Ciccacci C; Borgiani P; Pallone F
    Dig Liver Dis; 2014 Mar; 46(3):276-8. PubMed ID: 24360029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT findings and clinical activity in Crohn's disease.
    Minordi LM; Vecchioli A; Guidi L; Poloni G; Fedeli G; Bonomo L
    Clin Imaging; 2009; 33(2):123-9. PubMed ID: 19237055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active Crohn's disease is associated with low vitamin D levels.
    Jørgensen SP; Hvas CL; Agnholt J; Christensen LA; Heickendorff L; Dahlerup JF
    J Crohns Colitis; 2013 Nov; 7(10):e407-13. PubMed ID: 23403039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings.
    Sipponen T; Savilahti E; Kolho KL; Nuutinen H; Turunen U; Färkkilä M
    Inflamm Bowel Dis; 2008 Jan; 14(1):40-6. PubMed ID: 18022866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silent Crohn's Disease Predicts Increased Bowel Damage During Multiyear Follow-up: The Consequences of Under-reporting Active Inflammation.
    Bhattacharya A; Rao BB; Koutroubakis IE; Click B; Vargas EJ; Regueiro M; Schwartz M; Swoger JM; Babichenko D; Hartmann D; Rivers CR; Barrie A; Hashash JG; Dunn MA; Binion DG
    Inflamm Bowel Dis; 2016 Nov; 22(11):2665-2671. PubMed ID: 27753691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein.
    Takeyama H; Mizushima T; Iijima H; Shinichiro S; Uemura M; Nishimura J; Hata T; Takemasa I; Yamamoto H; Doki Y; Mori M
    Dig Dis Sci; 2015 Nov; 60(11):3418-23. PubMed ID: 26077975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.
    Forbes GM; Sturm MJ; Leong RW; Sparrow MP; Segarajasingam D; Cummins AG; Phillips M; Herrmann RP
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):64-71. PubMed ID: 23872668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of disease location on fecal calprotectin levels in Crohn's disease.
    Gecse KB; Brandse JF; van Wilpe S; Löwenberg M; Ponsioen C; van den Brink G; D'Haens G
    Scand J Gastroenterol; 2015 Jul; 50(7):841-7. PubMed ID: 25636819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimising monitoring in the management of Crohn's disease: a physician's perspective.
    Papay P; Ignjatovic A; Karmiris K; Amarante H; Milheller P; Feagan B; D'Haens G; Marteau P; Reinisch W; Sturm A; Steinwurz F; Egan L; Panés J; Louis E; Colombel JF; Panaccione R
    J Crohns Colitis; 2013 Sep; 7(8):653-69. PubMed ID: 23562672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose interferon gamma for refractory Crohn's disease.
    Debinski H; Forbes A; Kamm MA
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):403-6. PubMed ID: 9494846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum calprotectin as a biomarker for Crohn's disease.
    Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
    J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.
    Jones J; Loftus EV; Panaccione R; Chen LS; Peterson S; McConnell J; Baudhuin L; Hanson K; Feagan BG; Harmsen SW; Zinsmeister AR; Helou E; Sandborn WJ
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1218-24. PubMed ID: 18799360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn's Disease: Results from the CONNECT Study.
    Kwon JH; Im JP; Ye BD; Cheon JH; Jang HJ; Lee KM; Kim YS; Kim SW; Kim YH; Song GA; Han DS; Kim WH; Kim JS
    Gut Liver; 2016 Jul; 10(4):595-603. PubMed ID: 27021506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status.
    Trebble TM; Wootton SA; Stroud MA; Mullee MA; Calder PC; Fine DR; Moniz C; Arden NK
    Aliment Pharmacol Ther; 2004 May; 19(10):1063-71. PubMed ID: 15142195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [C-reactive protein in the evaluation of the activity of Crohn's disease].
    Gillard C; Brassinne A
    Acta Gastroenterol Belg; 1983; 46(1-2):39-46. PubMed ID: 6650095
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of C-reactive protein in the evaluation of activity in ulcerative colitis and Crohn's disease].
    Vucelić B; Krznarić Z; Sentić M; Milicić D; Korać B; Cvorisćec D; Stavljenić A
    Lijec Vjesn; 1990; 112(9-10):281-4. PubMed ID: 2093781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.